SUMMARY : Habu venom and the purified toxic principles (HR1 and HR2) were converted to toxoid with formalin.
INTRODUCTION
Administration of antivenin has widely been accepted as effective for the treatment of envenomation by snake bite (Kitajima, 1908; Grasset, 1957; Gitter and de Vries, 1968; Chapman, 1968; Reid, 1968) . Repeated use of antivenin, however, would cause serum disease. Furthermore, the serotherapy is effective only when applied soon after the bite before manifestation of tissue damage. The venom of Trimeresurus flavoviridis (Habu) contains lethal toxin(s) and at least two hemorrhagic principles which cause severe hemorrhage followed by necrosis of the envenomated soft tissues . The mortality of the snake bite has decreased greatly since the serotherapy was adopted in 1908 (Kitajima, 1908; Teruya, 1959; Sassa, 1956) . Since the toxic principles act very quickly, the victims often suffer from severe residual symptoms such as extensive necrosis of the muscle and other soft parts at the affected limb if they f aile to receive an adequate treatment immediately after the bite (Sawai et al., 1962) . Thus envenomation by the snake bite is still a serious problem among people in the southern islands of Japan.
From the action of the venom and the environmental conditions of the areas where the injuly takes place, active immunization is urgently required to prevent people in the remote islands from envenomation.
Attempts have been made by many workers at toxoiding venoms by treatment with f ormalin (Boquet and Vendrely, 1943; Christensen, 1947; Wiener, 1960; MorozPerlmutter et al., 1963) or other chemicals (Sawai et al., 1966; Okonogi and Hattori, 1968) , by irradiation with X-ray (Flowers, 1963) and by photo-oxidation (Kocholaty, 1966) . All these treatments not only detoxified venoms but also impaired the immunogenicity. Thus no toxoid preparation of high immunogenicity has ever been prepared. In 1968, the present authors succeeded in producing a toxoid from Habu venom by formalinization (Sadahiro et al., 1968 and Sadahiro, 1971a, b) . We demonstrated that the immunogenicity was excellent if the venom was detoxified with f ormalin added in several steps to a final concentration of 0.8 %. A preliminary report showed that one of our preparations was so highly immunogenic for monkeys that the inoculated animals prevented themselves from envenomation by the challenge with 10 mg venom . On the other hand, Okonogi and Hattori (1968) reported another method for toxoiding Habu venom which involves detoxification with 70 % alcohol followed by treatment with 0.1-1 % f ormalin.
To prepare toxoid preparations of consistently high immunogenicity for human use, a reliable method of standardization is prerequisite.
This paper describes details of the method for preparation of Habu toxoid (f ormol) -and proposes a procedure for standardization of the toxoid preparations.
MATERIALS AND METHODS
Habu Venoms : The venoms used in these experiments were pools of lyophilized venom taken from Trimeresurus flavoviridis.
Most specimens were obtained in Amami Ohshima Islands and some in Okinawa Islands. Although different batches of the venoms showed a slight variation in the relative amounts of the three main toxic components, HR1, HR2 and lethal toxin (see below), no immunological heterogeneity of the isolated toxic components was observed among the venom specimens including those from the Okinawa Islands (unpublished).
Purification of toxic principles from Habu Venom : The two hemorrhagic principles, HR1 and HR2, were separated by gel filtration on Sephadex G-100 as reported by Omori-Satoh et al. (1967) . Most lethal activity was found in HR1. The HR2 fraction was further purified by chromatography on Amberlite CG-50 as reported by Takahashi and Ohsaka (1970) .
Standard Habu Antivenin : National Standard Habu Antivenin No. 1 was used throughout this experiment (Kondo et al., 1971; Ministry of Health and Welfare, 1965) . This was a peptic digest of a pool of sera from horses immunized with crude Habu Venom.
The standard antivenin contained antibodies against HRl, HR2 and lethal toxin. Determination of toxicity : The lethal toxicity of the venom and purified toxins was determined by intravenous injection into mice weighing 14-17 g and expressed in LD50. The hemorrhagic activity was determined by intracutaneous injection into rabbits as described by Kondo et al. (1960) Estimation of protein : Protein content was estimated usually by measuring absorbance at 280 m,u with a 1-cm cell in a Hitachi Perkin-Elmer type 139 spectrophotometer.
A factor of 1.2 was used to convert A280 m,u to mg protein per ml from the fact that a solution containing crude venom at 1 mg/ml showed an absorbancy of 1.2 (Omori-Satoh et al., 1967) . Protein content of the final product of toxoid for immunization was determined by the micro-kjeldahl method. Detoxification with dihydrothioctic acid : This was carried out according to Sawai et al. (1966) . A 1 % solution of each of crude venom, HR1 and HR2 was detoxified with dihydrothioctic acid (DHTA) at 0.5 %. Excess reagent was removed by dialyzation after detoxification.
Preparation of adsorbed toxoid : To one volume of toxoid solution one volume of aluminum phosphate gel (Holt, 1950) was added and pH of the mixture was adjusted to 6.0 with N-HC1 or N-NaOH.
The aluminum content was approximately 1.3 mg per ml, unless specified.
Immunization with toxoids : Guinea pigs weighing 300-400 g were immunized with graded doses of each toxoid preparation.
Only adsorbed toxoids were used for immunization.
Eight animals were used for a dose unless otherwise specified. The injections were repeated several times usually at 4 weeks' intervals.
Each animal was bled at intervals and circulating antitoxins were determined.
Each serum specimen was titrated for the antihemorrhagic (anti-HR1 and anti-HR2) and for the antilethal Vol. 24 KONDO et al. activities by the method described elsewhere (Kondo et al., a, b, 1971 .
Challenging the immunized animals to crude venom or purified toxins : The immunized animals were injected intramuscularly on a femur with a crude venom or each purified hemorrhagic principle. The animals, if died, were autopsied immediately. Survived animals were killed with ether after 24-72 hr and examined for the local pathological changes.
RESULTS

Detoxification of Venom by Formalinization
Formalin at 0.8 % was required to detoxify a 1 % solution of crude Habu venom, but immunogenicity was more or less impaired at this concentration.
Immunogenicity was preserved well, however, if f ormalin was added in several steps as described in the , Materials and Method . Figure 1 shows the course of detoxif ication of a 1 % solution of a crude venom with f ormalin.
The hemorrhagic activity disappeared completely within 10 days. Similar experiments with different venom specimens showed that hemorrhagic activity disappeared usually within 10-14 days Groups of 8 guinea pigs received three injections of 0.5 ml of each toxoid at intervals of 4 weeks. The first and the second injections were given after bleeding . Logarithmic means of circulating antitoxin in each group were plotted .
---Show the lowest detectable level of antitoxin.
and the lethality within 5-7 days. The purified HR1 and HR2 were detoxified in a way essentially similar to that with the crude venom.
Immunogenicity of Toxoids Figure 2 shows typical patterns of antitoxin production with four f ormol toxoid preparations, viz, the crude, HR1, HR2 and mixed toxoids. The titers of cirdulating antitoxins are the geometric means of 8 animals.
Only the results of the groups inoculated with 0.5 ml of each preparation are shown in the figure . All the titers increased repidly at first and the rate of increase began to decrease after the 3 rd Fig. 3 Immunogenicities for guinea pigs of a crude and a mixed toxoids prepared with dihydrothioctic acid (DHTA).
Group of 10 guinea pigs received 4 injections of 2 ml of each toxoid at intervals of 4, 8 and 5 weeks.
Logarithmic means of circulating antitoxin in each group are plotted.
---Shows the lowest detectable level of antitoxin.
inoculation. Another experiment showed that 5 or more injections did not contribute to further increase in the antitoxin titers . In the crude toxoid group, anti-HR1 and anti-HR2 titers increased at similar rates. In the HR1 toxoid group a high titer of anti-HR1 developed with little anti-HR2, while the results was reversed in the HR2 group. In the mixed toxoid group, both anti-HR1 and anti-HR2 developed at similar rates. A tendency was observed that the antitoxin titers were higher with purified toxoids than with the crude one. Antilethal activity was about 40-80 units per ml with the HR1 and mixed toxoids while lower than 32 units per ml with the other toxoids. These facts may suggest that the purified toxoids are superior in the immunogenicity to the crude one. +Slight hemorrhage at the injection site only.
•} Doubtful hemorrhage at the injection site only,.
2) Each symbol in the table shows the symptom of an animal.
3) Only the ranges of the antihemorrhagic titers were given to show the difference in the antitoxin response among group immunized with 4 toxoids.
after the 3 rd injection and challenged with crude venom, HR1 or HR2 4 days after the bleeding. The animals were killed with ether 24 hr after the challenge to observe local pathological changes. The results are summarized in Table 1 . A definite protection against the challenge with crude venom was attained only in the groups immunized with crude or mixed toxoid; the animals in these groups possessed both anti-HR1 and anti-HR2. The HR1 or HR2 toxoid group was less resistant to the crude venom. The HR1 group was protected sufficiently against the challenge with HRl but not with HR2. To the contrary, the HR2 group showed a sufficient resistance to the challenge with HR2 but not with HR1.
In order to clarify the relationship between the antitoxin titers and the severity of the pathological changes, challenge experiments with crude venom were further carried out with a larger number of guinea pigs immunized with various batches of crude or mixed toxoid and the results are summarized in Fig. 4 . Only the titers of anti-HR1 were considered since HR1 is the main toxic component of the crude venom and most lethal toxin is associated with this fraction.
A certain correlation can be found between the anti-HR1 titer and the amount of venom tolerated. Fig. 4 Relationship between the circulating antitoxin in guinea pigs and resistance to the challenge with crude venom.
Determination of the Potency of the Toxoid Preparations
Animals received 3 injections of Habu toxoids (crude or mixed-Td) and circulating antitoxins were titrated 10 days after the last injection.
The animals were challenged with crude venom 2-3 days after bleeding. Only the titers of anti-HR1 are given in the figure. Unimmunized animals showed severe local symptom with 0.03 mg of the challenging venom and were killed with about 3 mg.
•¬ Survived with severe symptoms.
•› Survived with or without slight local symptoms.
venom. Thus, the potency of the toxoid preparations may be assessed by determining the circulating antitoxins of the animals immunized with them.
Since the absolute value of antitoxin varies greatly depending on the experimental conditions, we planned to express the potency by a value relative to a reference toxoid, as is the case with other toxoid preparations such as diphtheria and tetanus toxoids. Several toxoid preparations were examined for the dosage response curves. Guinea pigs were immunized with graded doses of each toxoid preparation.
Each animal received three injections of the same dosage at 4 weeks' intervals. Circulating antitoxins were determined 4 weeks after each injection. Since the antitoxin production was rather poor after the PREPARATION AND STANDARDIZATION OF HABU TOXOID
Fig. 5 Dose response curves after the second injection of Habu toxoids in guinea pigs.
Groups of 6-10 guinea pigs received two injections of various doses of toxoids at 4 weeks' interval.
Circulating antitoxins were titrated 10 days after the second injection.
Logarithmic means of antitoxins in each group were plotted.
•\•›•\ Anti HR1 with a crude toxoid No. 7.
(token from four separate experiments).
---•oe---Anti HR2 with a crude toxoid No. 7.
•\•¢•\ Anti HR1 with a HR1 toxoid and two mixed toxoids.
---•£---Anti HR2 with a HR2 toxoid and two mixed toxoids.
primary injection and the individual variation was considerably large, it seemed that the primary response might be unsuitable for the potency test. To the contrary, animals showed high antitoxin titers after the 3rd injection but the slopes of the dosage response curves were less steep within the dosage range of 0.1-2 ml of the toxoids than those in the secondary response. Therefore, only the secondary responses were considered for further experiments. Some of the results are summarized in Fig.  5 , in which the means of the antitoxin titers of 6-10 guinea pigs were plotted against the dosage.
The statistical analysis of the results showed that there was no reason to deny the lineality and the parallelism of the dosage response lines of various preparations in regard to both anti-HR1 and anti-HR2 (Table 2 ). The slopes (b) were 0.445 and 0.382, respectively for HR1 and HR2 toxoids. Table 3 shows relative potencies of some toxoid preparations, calculated by using a crude toxoid preparation (No. 7) as the reference.
Since anti-lethal antitoxin near the lowest detectable level was detected only in the groups immunized with larger doses of HR1 or the mixed toxoid, the anti-hemorrhagic titers (anti-HR1 and anti-HR2) alone were considered in this paper.
Vol. 24 KONDO et al. Table 2 . Analysis of variance ** Significant at 1 % level of probability
A Proposed Method for the Potency Test
At least 3 graded doses of each of the reference and test preparations are to be used. No less than 8 guinea pigs are to be used for each dosage. Each animal receives two successive injections of the same dosage at 4 weeks' interval. Circulating antitoxins of each immunized guinea pig are determined 10 days after the second injection for anti-HR1 and anti-HR2 and the relative potency of the test specimen calculated in terms of HR1 and HR2 toxoids. The crude toxoid No. 7 is to be used as the reference toxoid for the future experiment.
DISCUSSION
As shown in Fig. 2 , Habu venom or its derivatives treated with f ormalin produced antitoxins detectable by the authentic method; in other words, Habu venom could be toxoided with f ormalin. The reason for the failure to produce Habu toxoid may have been due to inadequate conditions for toxoiding as well as to the lack of the method for the potency test (see below). Mild treatment with formalin seemed to be important for keeping the immunogenicity.
Dihydrothioctic acid may not be a good toxoiding agent (see Fig. 3 ) so far as it is used according to the published method (Sawai et al., 291 PREPARATION AND STANDARDIZATION OF HABU TOXOID Table 3 . Relative potencies of various toxoids and the fiducial limits 1) Relative potencies were calculated on the basis of the protein content of the preparations determined by the micro-kjeldahl method. 2) Not determined.
3) The fiducial limit attained unusually wide since the experimental design was not suitable. 4) Not calculated due to the non-parallelism of the doses respons curves.
1966).
The alcohol precipitation method (Okonogi and Hattori, 1968) Habu venom contains several toxic principles which are serologically distinct each other . Among these toxic substances, HR1, HR2 and the lethal factor seem to be the main factors responsible for envenomation by snake bite, although some other factors may contribute to the symptom. Table 1 shows that animals immunized with HR1 or HR2 toxoid do not resist sufficiently to the challenge with crude venom, while those immunized with crude toxoid or mixed toxoid resist the challenge. This means that Habu toxoid is capable of producing enough antibodies to the main toxic principles to protect animals from envenomation by Habu bite. The fact also suggest that the mixed toxoid contains most of the important antigens necessary to furnish immunity to protect against the envenomation. This was confirmed also by the experiments in monkeys; the animals immunized with a mixed toxoid resisted the challenge with such a large amount of the venom as 10 mg . All above evidences provide a firm basis to show that the toxoid preparation containing adequate amounts of HR1 and HR2 toxoid may be useful for immunization of human beings. KONDO et al. It has been well known with other toxoid preparations that the immunogenicities vary greatly depending on the conditions of toxoiding.
It may be difficult to find optimal conditions for toxoiding each toxic component contained in a crude venom, since the behaviour to the toxoiding with f ormalin may be different from one toxic principle to another. The procedure described here is suitable to convert each toxic principle under optimal conditions. The method is also advantageous in that the composition of the toxoids can be adjusted so as to give an adequate proportion for practical use.
To produce toxoid preparations of high and constant potency, it is necessary to establish a reliable and accurate procedure for potency test.
One of the important reasons for the failure in the past to produce Habu toxoid of high immunogenicity may have been due to the lack of an adequate method for the potency test of toxoid preparations.
Since the toxoid preparation is a mixture of at least three kinds of toxoids, the potency should be determined separately for each component as in the case of other combined prophyractics.
It is evident that the toxin challenge method using a crude venom which is also a mixture of several toxins can not be applied for the accurate estimation of potency of Habu toxoid from the similar reason to the case of antitoxin titration . Challenge with separate toxins (HR1, HR2) may be useful theoretically, but it is not practical since a large number of animals should be used separately for assaying each componens.
The large amounts of purified toxins needed for the challenge may be another obstacle to the routine use of the latter method. To the ccntrary, antitoxin titration method described here is accurate and economic for estimation of the potency of both HR1 and HR2 toxoids. The fact that the titer of antitoxin seems to correlate considerably to the resistance against the venom (Fig. 4) justifies the antitoxin method.
An interpretation may be necessary, however, in regard to the antitoxin to the lethal factor.
Although the antitoxin potency was near the lowest detectable level, this may not necessarily mean that most immunogenicity of the lethal toxin had been destroyed during toxoiding. The failure to detect the circulating antitoxin in many of the immunized animals may have been due to the method for titration of the antilethal activity.
The method was at first established to titrate accurately the antivenins for therapy prepared from sera of hyperimmunized horses. The level of antitoxin which can be titrated accurately by the mouse method is over 63 u/ml (or 32 u/ml at least). This level of antitoxin is very high when we consider the fact that hyperimmunized horses possess the antitoxin in a range of 100-200 units of antilethal titer per ml. It may be rather difficult to produce the antitoxin measurable by the present method with only two injections of the toxoids in guinea pigs. Even so, the fact that the animals immunized with the mixed toxoid survived a fairly large amount of the crude venom may suggest that the immunogenicity of the lethal toxin was preserved after toxoiding. Further effort should be made to find out a method to evaluate the antilethal activity applicable for the standardization of Habu toxoid . PREPARATION AND STANDARDIZATION OF HABU TOXOID
